Search

Your search keyword '"RAMOS, STEPHANIE"' showing total 1,605 results

Search Constraints

Start Over You searched for: Author "RAMOS, STEPHANIE" Remove constraint Author: "RAMOS, STEPHANIE"
1,605 results on '"RAMOS, STEPHANIE"'

Search Results

5. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model

7. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

9. INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

10. Cool Subdwarf Investigations II: Multiplicity

12. Immunogenicity of a DNA vaccine candidate for COVID-19

14. Suntex

16. Communities of Practice in Academic Administration

19. Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1

22. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

24. The Roots of Traditional Literature Interwoven in the Magical Universe of Harry Potter

26. DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

27. Retrospective evaluation of excess death loss in feedlot cattle associated with in-feed tylosin application programs

28. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

29. Diseases

32. 578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

33. 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster

34. 579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine

35. Elicitation of immune responses against Nipah virus by an engineered synthetic DNA vaccine.

36. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

37. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

38. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

39. Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

41. Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

42. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine

43. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

45. Suntex: Weaving Solar Energy Into Building Skin.

46. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

47. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model

48. Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses

49. Programming mucosal immunity by targeting extramucosal dendritic cells with Oprl, a TLR2 ligand

Catalog

Books, media, physical & digital resources